Compare DOO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOO | ALKS |
|---|---|---|
| Founded | 1937 | 1987 |
| Country | Canada | Ireland |
| Employees | 17000 | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 4.5B |
| IPO Year | N/A | 2012 |
| Metric | DOO | ALKS |
|---|---|---|
| Price | $59.81 | $34.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | ★ $80.50 | $43.43 |
| AVG Volume (30 Days) | 628.1K | ★ 2.7M |
| Earning Date | 05-28-2026 | 04-24-2026 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | N/A | ★ $1,475,899,000.00 |
| Revenue This Year | $7.62 | $24.26 |
| Revenue Next Year | $5.54 | $4.47 |
| P/E Ratio | $338.95 | ★ $24.16 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $48.83 | $25.17 |
| 52 Week High | $81.89 | $36.48 |
| Indicator | DOO | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 40.12 | 58.99 |
| Support Level | N/A | $26.80 |
| Resistance Level | $81.52 | $35.47 |
| Average True Range (ATR) | 3.04 | 1.36 |
| MACD | -1.65 | 0.06 |
| Stochastic Oscillator | 35.75 | 42.89 |
BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested; Manitou was sold in the third quarter of fiscal 2026, and Telwater remains up for sale. At the end of fiscal 2026, the company sold its products through a network of more than 2,050 independent dealers and 140 distributors in around 110 countries.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.